SVA vs AAPL: Which Stock is Better?
Side-by-side comparison of Sinovac Biotech Ltd and Apple Inc in 2026
SVA
Sinovac Biotech Ltd
$6.47
AAPL
Apple Inc
$270.52
Key Metrics Comparison
| Metric | SVA | AAPL | Winner |
|---|---|---|---|
| Market Cap | $642.44M | N/A | SVA |
| P/E Ratio | 6.66 | 33.34 | SVA |
| EPS (TTM) | $0.97 | $7.90 | AAPL |
| Revenue Growth | 3.0% | 0.2% | SVA |
| Gross Margin | 86.8% | 47.3% | SVA |
Analyze SVA
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SVA or AAPL a better investment?
Comparing SVA and AAPL: Sinovac Biotech Ltd has a market cap of $642.44M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SVA and AAPL?
SVA (Sinovac Biotech Ltd) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SVA or AAPL?
Based on P/E ratios, SVA trades at a lower multiple (6.7x vs 33.3x).
Which is growing faster: SVA or AAPL?
SVA has higher revenue growth at 3.0% vs 0.2% for AAPL.
Which company is more profitable: SVA or AAPL?
Sinovac Biotech Ltd (SVA) has higher gross margins at 86.8% compared to 47.3% for AAPL.
Which is the larger company: SVA or AAPL?
Sinovac Biotech Ltd (SVA) is larger with a market cap of $642.44M compared to N/A for AAPL.
Should I buy SVA or AAPL in 2026?
Both SVA and AAPL have investment merit. SVA trades at $6.47 while AAPL trades at $270.52. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SVA and AAPL stock?
Key differences: Market Cap ($642.44M vs N/A), P/E Ratio (6.7x vs 33.3x), Revenue Growth (3.0% vs 0.2%), Gross Margin (86.8% vs 47.3%).